PharmaInformatic
PharmaInformatic helps pharmaceutical researchers speed up drug discovery by using AI to improve candidate selection and reduce late-stage failures. Its core technology combines expert systems, AI/ML, QSAR/QSPR, and ADME/Tox knowledge bases to generate predictive models and decision support. Key offerings include IMPACT-F for human bioavailability prediction and MolScore suites for identifying and prioritizing drug candidates. The company operates as a B2B SaaS/licensing provider serving pharmaceutical researchers and drug developers, and maintains plasma protein binding databases and related AI-powered models. It collaborates on research projects and has received recognition for its work in animal-free testing, signaling scale and market relevance.
PharmaInformatic
PharmaInformatic helps pharmaceutical researchers speed up drug discovery by using AI to improve candidate selection and reduce late-stage failures. Its core technology combines expert systems, AI/ML, QSAR/QSPR, and ADME/Tox knowledge bases to generate predictive models and decision support. Key offerings include IMPACT-F for human bioavailability prediction and MolScore suites for identifying and prioritizing drug candidates. The company operates as a B2B SaaS/licensing provider serving pharmaceutical researchers and drug developers, and maintains plasma protein binding databases and related AI-powered models. It collaborates on research projects and has received recognition for its work in animal-free testing, signaling scale and market relevance.